Related references
Note: Only part of the references are listed.Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Atopic dermatitis endotypes and implications for targeted therapeutics
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Epidemiology of adult atopic dermatitis
Ryan Sacotte et al.
CLINICS IN DERMATOLOGY (2018)
Psoriasis pathogenesis and the development of novel targeted immune therapies
Jason E. Hawkes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
IL-17 and IL-22 in immunity: Driving protection and pathology
Kilian Eyerich et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Successful use of secukinumab in an Asian patient with severe refractory atopic dermatitis
S. Noda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency
Romain Levy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
Shinji Noda et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Share Paper
